$CBRX Company News Columbia Labs slides on FDA setback

New Post Public Reply Private Reply Replies (0) Message Board

Jun 21, 2014 at 9:11 AM

$CBRX Company News

Columbia Labs slides on FDA setback 4:33 p.m. Feb. 27, 2012 - Val Brickates Kennedy
Columbia Labs shows signs of rebound 2:09 p.m. Jan. 24, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 23, 2012 - Sue Chang
Columbia Labs plunges on FDA vote 12:28 p.m. Jan. 23, 2012 - Val Brickates Kennedy
U.S. futures flat; RIM and PetMed shares active 10:14 a.m. Jan. 23, 2012 - Barbara Kollmeyer
Monday’s biggest gaining and declining stocks 5:31 p.m. Dec. 6, 2010 - Kate Gibson
Thursday's biggest stock gainers and decliners 6:58 p.m. April 26, 2007 - MarketWatch
Columbia Labs shares rise on Prochieve data 10:38 a.m. April 26, 2007 - Gabriel Madway
Monday's biggest stock gainers and decliners 6:54 p.m. Feb. 5, 2007 - Michael Baron
Columbia Labs shares tumble as trial fails to meet endpoint 11:16 a.m. Feb. 5, 2007 - Gabriel Madway
Columbia Labs shares fall on Phase III trial results 11:05 a.m. Feb. 5, 2007 - Gabriel Madway
Columbia Labs shares plunge 65% to $1.61 11:05 a.m. Feb. 5, 2007 - Gabriel Madway
Columbia Labs seeking $30M from private placement 9:27 a.m. March 13, 2006 - Leslie Wines
Columbia Labs seeks $30M from private placement 9:19 a.m. March 13, 2006 - Thomas Middleton
Columbia Labs promotes Robert Mills to president 8:41 a.m. Jan. 9, 2006 - Steve Gelsi
Columbia Labs' Wilkinson took post with NYSE pharma firm 8:34 a.m. Jan. 9, 2006 - Robert Daniel
Columbia Labs Pres and CEO Wilkinson resigns 8:34 a.m. Jan. 9, 2006 - Robert Daniel
Columbia Labs COO Robert Mills adds post of pres 8:33 a.m. Jan. 9, 2006 - Robert Daniel
Columbia pilot study suggests Prochieve pregnancy boost 6:31 a.m. June 21, 2005 - Kabir Chibber
Columbia Labs: Designing larger study 6:18 a.m. June 21, 2005 - Steve Goldstein

10-Q: COLUMBIA LABORATORIES INC 2:59 p.m. May 2, 2014 - Edgar Online - (EDG = 10Q, 10K)
Columbia Laboratories' CEO Discusses Q1 2014 Results - Earnings Call Transcript 1:25 p.m. April 29, 2014 - Seeking Alpha
Columbia Labs buys back shares 10:30 a.m. March 7, 2014 - Seeking Alpha
Columbia Labs: You did what? 10:30 a.m. March 7, 2014 - Seeking Alpha
Columbia Laboratories' CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:56 p.m. March 5, 2014 - Seeking Alpha
10-Q/A: COLUMBIA LABORATORIES INC 6:12 p.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Open Letter To Fellow Columbia Laboratories Shareholders 10:10 a.m. Jan. 6, 2014 - Seeking Alpha
Columbia Labs Needs A New Direction 9:00 a.m. Dec. 9, 2013 - Seeking Alpha
Columbia Laboratories Needs A Carl Icahn 10:37 a.m. Nov. 27, 2013 - Seeking Alpha
Ranking 50 Stocks By Free Cash Flow Yield 8:05 a.m. Nov. 26, 2013 - Seeking Alpha
Columbia Laboratories' CEO Discusses Q3 2013 Results - Earnings Call Transcript 1:31 p.m. Nov. 10, 2013 - Seeking Alpha
Columbia Laboratories Management Discusses Q2 2013 Results - Earnings Call Transcript 2:00 p.m. Aug. 7, 2013 - Seeking Alpha
Speculative Bio Stocks For Investors 10:29 a.m. May 8, 2013 - Seeking Alpha
Merck KGaA-CBRX Renew Agreement - Analyst Blog 3:00 p.m. April 11, 2013 - Zacks.com
Columbia Laboratories Management Discusses Q4 2012 Results - Earnings Call Transcript 1:40 p.m. March 14, 2013 - Seeking Alpha
Speculative Biotech Stocks That Could Bounce Part 2 10:54 a.m. Feb. 13, 2013 - Seeking Alpha
Columbia Laboratories Inc.: Recent Events Lead To An Opportune Entry Point 1:30 p.m. Dec. 21, 2012 - Seeking Alpha
Teva Wins FDA Approval, Galena Sees Positive Data: Healthcare Business Wrap 5:22 p.m. Oct. 26, 2012 - Wall St. Cheat Sheet
Today’s Market Winners and Losers 9:56 a.m. Oct. 26, 2012 - 247WallSt.com
Columbia Laboratories's CEO Discusses Q2 2012 Results - Earnings Call Transcript 6:18 p.m. Aug. 10, 2012 - Seeking Alpha

Columbia Laboratories Reports First Quarter 2014 Financial Results 6:50 a.m. April 29, 2014 - PR Newswire - PRF
Columbia Laboratories to Discuss First Quarter 2014 Financial Results on April 29th Conference Call 6:50 a.m. April 17, 2014 - PR Newswire - PRF
Molecular Profiles Strengthens US Presence To Drive Growth 5:00 a.m. April 15, 2014 - PR Newswire - PRF
Elusys Completes Commercial Manufacturing Process Validation for Anthrax Antitoxin ETI-204 9:00 a.m. April 8, 2014 - PR Newswire - PRF
Molecular Profiles Expands Technology With GMP Hot Melt Extrusion 5:00 a.m. April 8, 2014 - PR Newswire - PRF
Columbia Laboratories Repurchases 1.4 Million Shares of Common Stock from Actavis 7:50 a.m. March 7, 2014 - PR Newswire - PRF
Columbia Laboratories Reports Fourth Quarter and Full Year 2013 Financial Results 7:50 a.m. March 5, 2014 - PR Newswire - PRF
Columbia Laboratories Announces Board Changes 7:50 a.m. March 3, 2014 - PR Newswire - PRF
Columbia Laboratories to Discuss Fourth Quarter and Year End 2013 Financial Results on March 5 Conference Call 7:50 a.m. Feb. 26, 2014 - PR Newswire - PRF
Columbia Laboratories, Inc. Announces Restatement of Previously- Issued Unaudited Interim Consolidated Financial Statements for the Three- and Nine-Month Periods Ended September 30, 2013 7:07 p.m. Feb. 19, 2014 - PR Newswire - PRF
Columbia Laboratories to Present February 11th at BIO CEO & Investor Conference 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Columbia Laboratories Announces Preliminary Fourth Quarter and Year-End 2013 Results 7:00 a.m. Jan. 9, 2014 - PR Newswire
Luzich Partners Releases Open Letter to Columbia Laboratories Shareholders 9:00 a.m. Jan. 6, 2014 - BusinessWire
Molecular Profiles Joins Leading Consortium To Drive Paediatric Formulation Development 6:00 a.m. Dec. 19, 2013 - PR Newswire
Luzich Partners Releases Letter to Columbia Laboratories' Board of Directors 9:00 a.m. Dec. 9, 2013 - BusinessWire
Columbia Laboratories to receive One-time Payment from Actavis for CRINONE U.S. Manufacturing Rights 7:50 a.m. Nov. 14, 2013 - PR Newswire
Columbia Laboratories Reports Third Quarter 2013 Financial Results 7:50 a.m. Nov. 7, 2013 - GlobeNewswire
Columbia Laboratories to Discuss Third Quarter 2013 Financial Results on November 7 Conference Call 6:50 a.m. Oct. 24, 2013 - GlobeNewswire
Amended Class Action Lawsuit against Columbia Laboratories Dismissed without Prejudice 6:50 a.m. Oct. 23, 2013 - BusinessWire
Molecular Profiles Selected to Develop Topical & Oral Psoriasis Products for Telormedix 5:00 a.m. Sept. 23, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...